These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12114407)

  • 41. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas.
    Di GH; Lu JS; Song CG; Li HC; Shen ZZ; Shao ZM
    J Exp Clin Cancer Res; 2005 Dec; 24(4):601-7. PubMed ID: 16471323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yoshidome K; Nakahara M; Nakao K; Nakamura M; Kakudo K
    Clin Cancer Res; 2006 Feb; 12(4):1201-7. PubMed ID: 16489074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.
    Takano Y; Kato Y; Masuda M; Ohshima Y; Okayasu I
    J Pathol; 1999 Oct; 189(2):194-200. PubMed ID: 10547574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
    Balasenthil S; Barnes CJ; Rayala SK; Kumar R
    FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
    Barbareschi M; Maisonneuve P; Aldovini D; Cangi MG; Pecciarini L; Angelo Mauri F; Veronese S; Caffo O; Lucenti A; Palma PD; Galligioni E; Doglioni C
    Cancer; 2003 Aug; 98(3):474-83. PubMed ID: 12879463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
    Bièche I; Lidereau R
    Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of HRad17 mRNA in human breast cancer: correlation with lymph node metastasis.
    Kataoka A; Sadanaga N; Mimori K; Ueo H; Barnard GF; Sugimachi K; Auclair D; Chen LB; Mori M
    Clin Cancer Res; 2001 Sep; 7(9):2815-20. PubMed ID: 11555598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.
    Driouch K; Prydz H; Monese R; Johansen H; Lidereau R; Frengen E
    Oncogene; 2002 Mar; 21(12):1832-40. PubMed ID: 11896615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenovirus-mediated p16INK4 gene transfer significantly suppresses human breast cancer growth.
    Campbell I; Magliocco A; Moyana T; Zheng C; Xiang J
    Cancer Gene Ther; 2000 Sep; 7(9):1270-8. PubMed ID: 11023200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1).
    Tiainen M; Vaahtomeri K; Ylikorkala A; Mäkelä TP
    Hum Mol Genet; 2002 Jun; 11(13):1497-504. PubMed ID: 12045203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
    Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D
    Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours.
    Rowan A; Churchman M; Jefferey R; Hanby A; Poulsom R; Tomlinson I
    J Pathol; 2000 Oct; 192(2):203-6. PubMed ID: 11004696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest.
    Tiainen M; Ylikorkala A; Mäkelä TP
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9248-51. PubMed ID: 10430928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BRCA1 gene expression in breast cancer in Kuwait: correlation with prognostic parameters.
    Amirrad M; Al-Mulla F; Varadharaj G; John B; Saji T; Anim JT
    Med Princ Pract; 2005; 14(2):67-72. PubMed ID: 15785095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NIP1/DUOXA1 expression in epithelial breast cancer cells: regulation of cell adhesion and actin dynamics.
    Ostrakhovitch EA; Li SS
    Breast Cancer Res Treat; 2010 Feb; 119(3):773-86. PubMed ID: 19322654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors.
    Brattsand G
    Br J Cancer; 2000 Aug; 83(3):311-8. PubMed ID: 10917544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two novel mutations and a new STK11/LKB1 gene isoform in Peutz-Jeghers patients.
    Resta N; Stella A; Susca FC; Di Giacomo M; Forleo G; Miccolis I; Rossini FP; Genuardi M; Piepoli A; Grammatico P; Guanti G
    Hum Mutat; 2002 Jul; 20(1):78-9. PubMed ID: 12112668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen and progesterone receptor expression and proliferation in breast cancer cells, studied with flow cytometry.
    Scheres HM; Schutte B; De Goij AF; Bosman FT
    Acta Histochem Suppl; 1990; 40():71-6. PubMed ID: 2091049
    [No Abstract]   [Full Text] [Related]  

  • 60. Downregulation and antiproliferative role of FHL3 in breast cancer.
    Niu C; Yan Z; Cheng L; Zhu J; Zhang H; Xu X; Lin J; Ye Q
    IUBMB Life; 2011 Sep; 63(9):764-71. PubMed ID: 22362714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.